Optimal timing of surgery for active infective endocarditis with cerebral complications: a Japanese multicentre study
- PMID: 26968761
- DOI: 10.1093/ejcts/ezw035
Optimal timing of surgery for active infective endocarditis with cerebral complications: a Japanese multicentre study
Abstract
Objectives: The aim of this study was to investigate the effect of the timing of valve surgery on the clinical outcomes of patients with active infective endocarditis (IE) accompanied by cerebral complications.
Methods: We retrospectively analysed a cohort of 568 patients, comprising 118 with non-haemorrhagic cerebral infarction (CI), 54 with intracranial haemorrhage (ICH) and 396 without cerebral events (C; control), who underwent surgery for left-sided active IE in 15 Japanese institutes from 2000 to 2011. The mean age was 58.4 ± 16.9 years in the CI group; 54.5 ± 17.4 years in the ICH group and 56.9 ± 16.0 years in the C group. Clinical outcomes were analysed according to the timing of surgery after the diagnosis of CI or ICH was made.
Results: In the CI group, there were 9 (7.6%) hospital deaths, 13 (11%) new cerebral events and 1 (0.8%) redo valve surgery. In the ICH group, there were 3 (5.6%) hospital deaths, 8 (14.8%) new cerebral events and 2 (3.7%) redo valve surgeries. In the C group, there were 36 (9.1%) hospital deaths, 23 (5.8%) new cerebral events and 9 (2.3%) redo valve surgeries. Risk factors for hospital death were prosthetic valve endocarditis (P = 0.045), high C-reactive protein (CRP; P < 0.001) and the elderly (P < 0.001) in the CI group. Delayed surgery (2 weeks after CI) seemed result in a higher incidence of hospital death in the CI group. Patients who had surgery between 15 and 28 days or after 29 days from the onset of CI had higher incidences of hospital death [odds ratio 5.90 (P = 0.107) and 4.92 (P = 0.137), respectively] compared with those who had surgery within 7 days. In the ICH group, risk factors for hospital death were high CRP (P = 0.002) and elderly (P < 0.001). Contrary to CI patients, patients who had surgery between 8 and 21 days or after 22 days after the onset of ICH had lower incidences of hospital death [odds ratio 0.79 (P = 0.843) and 0.12 (P = 0.200), respectively] compared with those who had surgery within 7 days.
Conclusions: Although statistically insignificant, early surgery in active IE patients with CI is safe, but very early surgery (within 7 days) should be avoided in patients with ICH.
Keywords: Cerebral complications; Infective endocarditis; Timing of surgery.
© The Author 2016. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
Comment in
-
Early valve repair or replacement is not generally contraindicated in patients with infective endocarditis and stroke with or without intracranial haemorrhage.Eur J Cardiothorac Surg. 2016 Aug;50(2):383-4. doi: 10.1093/ejcts/ezw090. Epub 2016 Mar 16. Eur J Cardiothorac Surg. 2016. PMID: 26984981 No abstract available.
Similar articles
-
Valve surgery in active endocarditis patients complicated by intracranial haemorrhage: the influence of the timing of surgery on neurological outcomes.Eur J Cardiothorac Surg. 2014 Jun;45(6):1082-8. doi: 10.1093/ejcts/ezt547. Epub 2014 Jan 10. Eur J Cardiothorac Surg. 2014. PMID: 24412832
-
Intracranial haemorrhage in infective endocarditis.Arch Cardiovasc Dis. 2018 Dec;111(12):712-721. doi: 10.1016/j.acvd.2018.03.009. Epub 2018 Jun 5. Arch Cardiovasc Dis. 2018. PMID: 29884600
-
Surgical management of infective endocarditis associated with cerebral complications. Multi-center retrospective study in Japan.J Thorac Cardiovasc Surg. 1995 Dec;110(6):1745-55. doi: 10.1016/S0022-5223(95)70038-2. J Thorac Cardiovasc Surg. 1995. PMID: 8523887
-
What is the optimal timing for surgery in infective endocarditis with cerebrovascular complications?Interact Cardiovasc Thorac Surg. 2012 Jan;14(1):72-80. doi: 10.1093/icvts/ivr010. Epub 2011 Nov 18. Interact Cardiovasc Thorac Surg. 2012. PMID: 22108925 Free PMC article. Review.
-
Impact of stroke on therapeutic decision making in infective endocarditis.J Neurol. 2010 Mar;257(3):315-21. doi: 10.1007/s00415-009-5364-3. Epub 2009 Oct 30. J Neurol. 2010. PMID: 19876684 Review.
Cited by
-
A 20-year experience with cryopreserved allografts as the valve replacement of choice in aortic root reconstruction for destructive endocarditis with abscess formation.Interact Cardiovasc Thorac Surg. 2022 Jul 9;35(2):ivac188. doi: 10.1093/icvts/ivac188. Interact Cardiovasc Thorac Surg. 2022. PMID: 35786719 Free PMC article.
-
Infective Endocarditis: Update on Epidemiology, Outcomes, and Management.Curr Cardiol Rep. 2018 Aug 16;20(10):86. doi: 10.1007/s11886-018-1043-2. Curr Cardiol Rep. 2018. PMID: 30117004 Review.
-
Prognosis and Treatment Effectiveness of Austrian Syndrome: A Case Report and Systematic Review.Cureus. 2024 Dec 2;16(12):e74971. doi: 10.7759/cureus.74971. eCollection 2024 Dec. Cureus. 2024. PMID: 39744262 Free PMC article.
-
Native Infective Endocarditis: A State-of-the-Art-Review.Microorganisms. 2024 Jul 19;12(7):1481. doi: 10.3390/microorganisms12071481. Microorganisms. 2024. PMID: 39065249 Free PMC article. Review.
-
Adding Fuel to the Fire: Infective Endocarditis and the Challenge of Cerebrovascular Complications.Curr Cardiol Rep. 2023 May;25(5):349-356. doi: 10.1007/s11886-023-01856-z. Epub 2023 Mar 27. Curr Cardiol Rep. 2023. PMID: 36971959 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous